Phathom Pharmaceuticals reported a gross margin of 79.68% and a net margin of -23.64% for the quarter ended Jun 2026. These financial ratios cover 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||||
| Gross Margin | 75.51% | 77.72% | 81.21% | 85.59% | 87.14% | 86.94% | 87.25% | 87.50% | 86.72% | 79.42% | 79.68% | |||||||||||||||||||||
| EBT Margin | -11,665.10% | -4,331.01% | -1,248.50% | -523.29% | -251.15% | -330.64% | -191.52% | -60.53% | -36.72% | -50.66% | -23.64% | |||||||||||||||||||||
| EBIT Margin | -10,245.60% | -3,658.68% | -1,055.43% | -432.95% | -200.30% | -276.53% | -151.69% | -30.85% | -10.29% | -26.55% | -5.34% | |||||||||||||||||||||
| EBITDA Margin | -10,245.60% | -3,658.68% | -1,055.43% | -432.95% | -200.30% | -276.53% | -151.69% | -30.85% | -10.29% | -26.55% | -5.34% | |||||||||||||||||||||
| Operating Margin | -10,245.60% | -3,658.68% | -1,055.43% | -432.95% | -200.30% | -276.53% | -151.69% | -30.85% | -10.29% | -26.55% | -5.34% | |||||||||||||||||||||
| Net Margin | -11,665.10% | -4,331.01% | -1,248.50% | -523.29% | -251.15% | -330.64% | -191.52% | -60.53% | -36.72% | -50.66% | -23.64% | |||||||||||||||||||||
| FCF Margin | -6,155.57% | -3,611.92% | -966.23% | -389.05% | -213.93% | -297.96% | -158.98% | -28.57% | -10.56% | -27.13% | -2.60% | |||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 0.11M | 0.66M | 1.33M | 1.82M | 2.64M | 3.16M | 3.19M | 3.30M | 3.52M | 4.56M | 6.01M | 7.11M | ||||||||||||||||||||
| Assets AverageAssets Avg. | 221.48M | 208.90M | 169.24M | 181.28M | 207.72M | 183.37M | 154.41M | 204.52M | 251.02M | 325.42M | 385.17M | 337.94M | 353.21M | 382.68M | 336.26M | 272.21M | 245.25M | 249.72M | 282.13M | 316.10M | ||||||||||||
| Invested CapitalInvested Cap. | 191.79M | 161.83M | 129.07M | 85.43M | 67.45M | 20.45M | 6.44M | 115.41M | 81.49M | 65.08M | 0.52M | -59.41M | -11.38M | -52.17M | -135.13M | -200.69M | -215.44M | -229.08M | -173.28M | -179.69M | ||||||||||||
| Asset Utilization RatioAsset Util. | 0.00 | 0.01 | 0.03 | 0.07 | 0.14 | 0.24 | 0.42 | 0.60 | 0.70 | 0.73 | 0.76 | |||||||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -22.31 | -11.91 | -13.74 | -8.00 | -4.58 | -4.86 | -3.26 | -3.30 | -3.53 | -5.36 | -4.07 | -4.35 | -3.83 | -3.20 | -4.36 | -3.42 | -0.95 | -0.36 | -0.98 | -0.26 | ||||||||||||
| Debt Ratio | 0.39 | 0.47 | 0.61 | 0.43 | 0.46 | 0.58 | 0.67 | 0.37 | 0.42 | 0.33 | 0.42 | 0.55 | 0.45 | 0.53 | 0.69 | 0.82 | 0.86 | 0.81 | 0.54 | 0.50 | ||||||||||||
| Times Interest Earned | -22.31 | -11.91 | -13.74 | -8.00 | -4.58 | -4.86 | -3.26 | -3.30 | -3.53 | -5.36 | -4.07 | -4.35 | -3.83 | -3.20 | -4.36 | -3.42 | -0.95 | -0.36 | -0.98 | -0.26 | ||||||||||||
| Valuation | ||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -27.87 | -16.76 | -12.77 | -6.36 | -8.92 | -8.47 | -8.22 | -19.80 | -13.69 | -6.65 | -7.51 | -6.60 | -14.44 | -7.47 | -4.63 | -8.89 | -27.90 | -56.04 | -29.88 | -49.48 | ||||||||||||
| Price to SalesP/S | 776.05 | 325.07 | 82.41 | 75.54 | 18.76 | 15.31 | 17.02 | 16.89 | 20.58 | 15.14 | 11.70 | |||||||||||||||||||||
| Price to BookP/B | 9.32 | 8.32 | 13.65 | -46.27 | -17.25 | -6.22 | -3.45 | 46.08 | -33.15 | -7.27 | -4.19 | -2.58 | -6.60 | -2.19 | -1.29 | -1.66 | -1.98 | -2.70 | -2.62 | -2.52 | ||||||||||||
| Enterprise Value | 739.90M | 416.74M | 380.62M | 115.97M | 258.53M | 309.39M | 181.02M | 561.70M | 372.58M | 145.01M | 296.43M | 324.49M | 897.76M | 256.24M | 221.45M | 519.87M | 698.16M | 1,052.01M | 698.84M | 683.42M | ||||||||||||
| EV to EBIT | -22.33 | -12.61 | -10.04 | -2.56 | -6.08 | -6.63 | -6.02 | -17.72 | -10.45 | -2.08 | -4.24 | -4.20 | -12.68 | -4.31 | -2.81 | -8.68 | -45.72 | -177.46 | -45.15 | -172.36 | ||||||||||||
| EV to EBITDA | -22.33 | -12.61 | -10.04 | -2.56 | -6.08 | -6.63 | -6.02 | -17.72 | -10.45 | -2.08 | -4.24 | -4.20 | -12.68 | -4.31 | -2.81 | -8.68 | -45.72 | -177.46 | -45.15 | -172.36 | ||||||||||||
| Market Capitalization | 964.52M | 600.16M | 519.22M | 323.86M | 455.87M | 465.28M | 311.10M | 811.07M | 589.11M | 529.27M | 621.53M | 603.59M | 1,235.30M | 556.37M | 436.63M | 672.30M | 836.18M | 1,184.84M | 882.60M | 868.76M | ||||||||||||
| Price to FCFP/FCF | -33.17 | -14.51 | -11.57 | -12.41 | -12.97 | -11.22 | -7.80 | -36.52 | -16.76 | -12.61 | -9.00 | -8.53 | -19.42 | -8.77 | -5.14 | -10.71 | -59.13 | -194.78 | -55.80 | -450.13 | ||||||||||||
| EV to FCF | -25.44 | -10.08 | -8.48 | -4.44 | -7.36 | -7.46 | -4.54 | -25.29 | -10.60 | -3.45 | -4.29 | -4.59 | -14.11 | -4.04 | -2.61 | -8.28 | -49.37 | -172.94 | -44.18 | -354.10 | ||||||||||||
| EV to CFO | -25.46 | -10.10 | -8.50 | -4.51 | -7.38 | -7.54 | -4.56 | -25.30 | -11.67 | -3.31 | -4.29 | -4.59 | -14.12 | -4.04 | -2.61 | -8.29 | -49.46 | -210.36 | -44.66 | -354.10 | ||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -10,245.60% | -3,658.68% | -1,055.43% | -432.95% | -200.30% | -276.53% | -151.69% | -30.85% | -10.29% | -26.55% | -5.34% | |||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -79.77% | -71.10% | -88.32% | -93.29% | -85.93% | -109.74% | -117.61% | -82.50% | -63.46% | -58.37% | -60.63% | -86.89% | -100.00% | -93.44% | -109.21% | -149.12% | -140.32% | -135.96% | -61.49% | -25.04% | ||||||||||||
| Return on Assets [ROA]ROA | -72.12% | -67.89% | -87.24% | -89.37% | -85.92% | -107.77% | -126.15% | -90.37% | -70.44% | -61.89% | -63.97% | -87.84% | -96.08% | -87.36% | -102.84% | -121.23% | -111.89% | -88.52% | -55.40% | -31.07% |